Logo image of RYDE

RYDE GROUP LTD-A (RYDE) Stock Fundamental Analysis

NYSEARCA:RYDE - American Stock Exchange - KYG7733R1020 - Common Stock - Currency: USD

0.3628  0 (-0.6%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RYDE. RYDE was compared to 39 industry peers in the Ground Transportation industry. The financial health of RYDE is average, but there are quite some concerns on its profitability. RYDE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year RYDE has reported negative net income.
In the past year RYDE has reported a negative cash flow from operations.
RYDE Yearly Net Income VS EBIT VS OCF VS FCFRYDE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -328.07%, RYDE is doing worse than 97.37% of the companies in the same industry.
RYDE's Return On Equity of -820.83% is on the low side compared to the rest of the industry. RYDE is outperformed by 89.47% of its industry peers.
Industry RankSector Rank
ROA -328.07%
ROE -820.83%
ROIC N/A
ROA(3y)-131.35%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RYDE Yearly ROA, ROE, ROICRYDE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -1K -2K -3K

1.3 Margins

RYDE's Gross Margin of 32.62% is on the low side compared to the rest of the industry. RYDE is outperformed by 63.16% of its industry peers.
RYDE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RYDE Yearly Profit, Operating, Gross MarginsRYDE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -50 -100

More info and screens

6

2. Health

2.1 Basic Checks

RYDE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RYDE has less shares outstanding
RYDE has a better debt/assets ratio than last year.
RYDE Yearly Shares OutstandingRYDE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M
RYDE Yearly Total Debt VS Total AssetsRYDE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 1M 2M 3M 4M 5M

2.2 Solvency

Based on the Altman-Z score of -13.00, we must say that RYDE is in the distress zone and has some risk of bankruptcy.
RYDE has a worse Altman-Z score (-13.00) than 86.84% of its industry peers.
There is no outstanding debt for RYDE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -13
ROIC/WACCN/A
WACC8.36%
RYDE Yearly LT Debt VS Equity VS FCFRYDE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 2M -2M 4M -4M -6M

2.3 Liquidity

A Current Ratio of 1.49 indicates that RYDE should not have too much problems paying its short term obligations.
RYDE has a better Current ratio (1.49) than 84.21% of its industry peers.
A Quick Ratio of 1.49 indicates that RYDE should not have too much problems paying its short term obligations.
RYDE's Quick ratio of 1.49 is amongst the best of the industry. RYDE outperforms 86.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.49
RYDE Yearly Current Assets VS Current LiabilitesRYDE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for RYDE have decreased strongly by -219.70% in the last year.
RYDE shows a decrease in Revenue. In the last year, the revenue decreased by -7.21%.
EPS 1Y (TTM)-219.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-293.06%
Revenue 1Y (TTM)-7.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-16.36%

3.2 Future

The Earnings Per Share is expected to grow by 17.16% on average over the next years. This is quite good.
The Revenue is expected to grow by 27.17% on average over the next years. This is a very strong growth
EPS Next Y-60.76%
EPS Next 2Y22.69%
EPS Next 3Y17.16%
EPS Next 5YN/A
Revenue Next Year39.14%
Revenue Next 2Y30.24%
Revenue Next 3Y27.17%
Revenue Next 5YN/A

3.3 Evolution

RYDE Yearly Revenue VS EstimatesRYDE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
RYDE Yearly EPS VS EstimatesRYDE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RYDE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RYDE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RYDE Price Earnings VS Forward Price EarningsRYDE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RYDE Per share dataRYDE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as RYDE's earnings are expected to grow with 17.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.69%
EPS Next 3Y17.16%

More info and screens

0

5. Dividend

5.1 Amount

RYDE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RYDE GROUP LTD-A

NYSEARCA:RYDE (2/5/2025, 11:41:08 AM)

0.3628

0 (-0.6%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)10-23 2024-10-23/bmo
Earnings (Next)N/A N/A
Inst Owners0.3%
Inst Owner ChangeN/A
Ins Owners5.21%
Ins Owner ChangeN/A
Market Cap9.54M
Analysts82.86
Price Target2.04 (462.29%)
Short Float %2.77%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-77.78%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-457.14%
EPS NY rev (3m)-457.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.99
P/FCF N/A
P/OCF N/A
P/B 4.03
P/tB 5.19
EV/EBITDA N/A
EPS(TTM)-1.1
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.37
BVpS0.09
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -328.07%
ROE -820.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.62%
FCFM N/A
ROA(3y)-131.35%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 105.98%
Cap/Sales 3.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 1.49
Altman-Z -13
F-Score4
WACC8.36%
ROIC/WACCN/A
Cap/Depr(3y)133.76%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.46%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-219.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-293.06%
EPS Next Y-60.76%
EPS Next 2Y22.69%
EPS Next 3Y17.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-16.36%
Revenue Next Year39.14%
Revenue Next 2Y30.24%
Revenue Next 3Y27.17%
Revenue Next 5YN/A
EBIT growth 1Y-268.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year59.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.03%
OCF growth 3YN/A
OCF growth 5YN/A